Table 5.
Characteristics | Older | Younger | p-value |
---|---|---|---|
Treatment outcomes in pulmonary TB |
n = 173 |
n = 222 |
|
Favorable |
167 (97) |
208 (94) |
0.251 |
Unfavorable |
6 (3) |
14 (6) |
|
Adverse drug reactions in all patients |
n = 199 |
n = 271 |
|
Hepatotocixity* |
6 (3) |
13 (5) |
0.338 |
Skin rash or itching |
15 (8) |
25 (9) |
0.642 |
Gastrointestinal† problems |
20 (10) |
10 (4) |
0.009 |
Optic neuropathy |
2 (1) |
8 (3) |
0.265 |
Thrombocytopenia | 2 (1) | 2 (1) | 1.0 |
The data are presented as n (%).
If there are more than one side effects for one patients, all side effects were recorded.
*: Hepatotoxicity was defined when liver transaminase levels exceeded 120 IU/L.
†:Gastrointestinal problems were problems of gastrointestinal tract for example nausea, vomiting, diarrhea, and dyspepsia etc.